Stockreport

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Ascentage Pharma Group International - American Depository Shares  (AAPG) 
PDF Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million)Sales of Olverembatinib increased 81% year-over-ye [Read more]